| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 679,956 | 612,740 | 550,170 | 568,551 | | Cost of Revenue | 985,861 | (314,402) | 314,402 | 319,735 | | | Gross Profit | (305,905) | 927,142 | 235,768 | 248,816 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (594,381) | 696,698 | 52,497 | 48,065 | | Non Recurring | 192 | 10 | 449,798 | 39 | | Others | 74,854 | 73,242 | 68,843 | 71,662 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 214,406 | 157,192 | (335,370) | 129,050 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,493 | 5,509 | 1,114 | 9,375 | | Earnings Before Interest And Taxes | (3,026) | 162,701 | (334,256) | 138,594 | | Interest Expense | (144,827) | 76,575 | 68,252 | 73,972 | | Income Before Tax | 141,801 | 86,126 | (402,508) | 64,622 | | Income Tax Expense | 50,165 | 34,137 | 10,571 | 28,215 | | Minority Interest |
-
|
-
|
-
| 169 | | | | Net Income From Continuing Ops | 91,636 | 51,989 | (413,079) | 36,407 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 91,636 | 51,989 | (413,079) | 36,407 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $91,636 | $51,989 | ($413,079) | $36,407 |
|
0.11% Nasdaq 
0.01%
Income Statement
